Search

Your search keyword '"Dailey, Roger A."' showing total 306 results
Start Over Author "Dailey, Roger A."
306 results on '"Dailey, Roger A."'

1. Inflammation and Fibrosis in Orbital Inflammatory Disease: A Histopathologic Analysis.

Author

Verma, Rohan, Chen, Allison, Choi, Dongseok, Wilson, David, Grossniklaus, Hans, Dailey, Roger, Ng, John, Steele, Eric, Planck, Stephen, Czyz, Craig, Korn, Bobby, Kikkawa, Don, Foster, Jill, Kazim, Michael, Harris, Gerald, Edward, Deepak, Al Maktabi, Azza, and Rosenbaum, James

Subjects
Humans, Orbit, Retrospective Studies, Inflammation, Graves Ophthalmopathy, Sarcoidosis, Fibrosis
Abstract

PURPOSE: The purpose of this study was to compare the histopathologic inflammation and fibrosis of orbital adipose tissue in orbital inflammatory disease (OID) specimens. METHODS: In this retrospective cohort study, inflammation, and fibrosis in orbital adipose tissue from patients with thyroid-associated orbitopathy (TAO), granulomatosis with polyangiitis (GPA), sarcoidosis, nonspecific orbital inflammation (NSOI), and healthy controls were scored by 2 masked ocular pathologists. Both categories were scored on a scale of 0 to 3 with scoring criteria based on the percentage of specimens containing inflammation or fibrosis, respectively. Tissue specimens were collected from oculoplastic surgeons at 8 international centers representing 4 countries. Seventy-four specimens were included: 25 with TAO, 6 with orbital GPA, 7 with orbital sarcoidosis, 24 with NSOI, and 12 healthy controls. RESULTS: The mean inflammation and fibrosis scores for healthy controls were 0.0 and 1.1, respectively. Orbital inflammatory disease groups inflammation (I) and fibrosis (F) scores, formatted [I, F] with respective p -values when compared to controls, were: TAO [0.2, 1.4] ( p = 1, 1), GPA [1.9, 2.6] ( p = 0.003, 0.009), sarcoidosis [2.4, 1.9] ( p = 0.001, 0.023), and NSOI [1.3, 1.8] ( p ≤ 0.001, 0.018). Sarcoidosis had the highest mean inflammation score. The pairwise analysis demonstrated that sarcoidosis had a significantly higher mean inflammation score than NSOI ( p = 0.036) and TAO ( p < 0.0001), but no difference when compared to GPA. GPA had the highest mean fibrosis score, with pairwise analysis demonstrating a significantly higher mean fibrosis score than TAO ( p = 0.048). CONCLUSIONS: Mean inflammation and fibrosis scores in TAO orbital adipose tissue samples did not differ from healthy controls. In contrast, the more intense inflammatory diseases such as GPA, sarcoidosis, and NSOI did demonstrate higher histopathologic inflammation and fibrosis. This has implications in prognosis, therapeutic selection, and response monitoring in orbital inflammatory disease.

Published
2023

2. Face-Lift

Author

Murdock, Jennifer, Dailey, Roger A., Steele, Eric, Section editor, Ng, John, Section editor, Albert, Daniel M., editor, Miller, Joan W., editor, Azar, Dimitri T., editor, and Young, Lucy H., editor

Published
2022
Full Text
View/download PDF

5. Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling

Author

Rosenbaum, James T, Choi, Dongseok, Wilson, David J, Grossniklaus, Hans E, Harrington, Christina A, Sibley, Cailin H, Dailey, Roger A, Ng, John D, Steele, Eric A, Czyz, Craig N, Foster, Jill A, Tse, David, Alabiad, Chris, Dubovy, Sander, Parekh, Prashant K, Harris, Gerald J, Kazim, Michael, Patel, Payal J, White, Valerie A, Dolman, Peter J, Korn, Bobby S, Kikkawa, Don O, Edward, Deepak P, Alkatan, Hind M, al-Hussain, Hailah, Yeatts, R Patrick, Selva, Dinesh, Stauffer, Patrick, and Planck, Stephen R

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Genetics, Clinical Research, Autoimmune Disease, Biotechnology, Aetiology, 2.1 Biological and endogenous factors, Adult, Biomarkers, Case-Control Studies, Female, Gene Expression Profiling, Granulomatosis with Polyangiitis, Graves Ophthalmopathy, Humans, Inflammation, Male, Middle Aged, Oligonucleotide Array Sequence Analysis, Orbital Pseudotumor, Sarcoidosis, Granulomatosis with polyangiitis, Orbital pseudotumor, Orbit pathology, Molecular pathology, Gene expression profiling, Microarray analysis, Oncology & Carcinogenesis, Clinical sciences
Abstract

Biopsies and ANCA testing for limited forms of granulomatosis with polyangiitis (GPA) are frequently non-diagnostic. We characterized gene expression in GPA and other causes of orbital inflammation. We tested the hypothesis that a sub-set of patients with non-specific orbital inflammation (NSOI, also known as pseudotumor) mimics a limited form of GPA. Formalin-fixed, paraffin-embedded orbital biopsies were obtained from controls (n=20) and patients with GPA (n=6), NSOI (n=25), sarcoidosis (n=7), or thyroid eye disease (TED) (n=20) and were divided into discovery and validation sets. Transcripts in the tissues were quantified using Affymetrix U133 Plus 2.0 microarrays. Distinct gene expression profiles for controls and subjects with GPA, TED, or sarcoidosis were evident by principal coordinate analyses. Compared with healthy controls, 285 probe sets had elevated signals in subjects with GPA and 1472 were decreased (>1.5-fold difference, false discovery rate adjusted p

Published
2015

12. Gene Expression Profiling and Heterogeneity of Nonspecific Orbital Inflammation Affecting the Lacrimal Gland

Author

Rosenbaum, James T., Choi, Dongseok, Harrington, Christina A., Wilson, David J., Grossniklaus, Hans E., Sibley, Cailin H., Salek, Sherveen S., Ng, John D., Dailey, Roger A., Steele, Eric A., Hayek, Brent, Craven, Caroline M., Edward, Deepak P., Maktabi, Azza M. Y., Al Hussain, Hailah, White, Valerie A., Dolman, Peter J., Czyz, Craig N., Foster, Jill A., Harris, Gerald J., Bee, Youn-Shen, Tse, David T., Alabiad, Chrisfouad R., Dubovy, Sander R., Kazim, Michael, Selva, Dinesh, Yeatts, R. Patrick, Korn, Bobby S., Kikkawa, Don O., Silkiss, Rona Z., Sivak-Callcott, Jennifer A., Stauffer, Patrick, and Planck, Stephen R.

Published
2017
Full Text
View/download PDF

13. Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment

Author

Douglas, Raymond S., primary, Kahaly, George J., additional, Ugradar, Shoaib, additional, Elflein, Heike, additional, Ponto, Katharina A., additional, Fowler, Brian T., additional, Dailey, Roger, additional, Harris, Gerald J., additional, Schiffman, Jade, additional, Tang, Rosa, additional, Wester, Sara, additional, Jain, Amy Patel, additional, Marcocci, Claudio, additional, Marinò, Michele, additional, Antonelli, Alessandro, additional, Eckstein, Anja, additional, Führer-Sakel, Dagmar, additional, Salvi, Mario, additional, Sile, Saba, additional, Francis-Sedlak, Megan, additional, Holt, Robert J., additional, and Smith, Terry J., additional

Published
2022
Full Text
View/download PDF

16. Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study

Author

Douglas, Raymond S., Kahaly, George J., Ugradar, Shoaib, Elflein, Heike, Ponto, Katharina A., Fowler, Brian T., Dailey, Roger, Harris, Gerald J., Schiffman, Jade, Tang, Rosa, Wester, Sara, Jain, Amy Patel, Marcocci, Claudio, Marinò, Michele, Antonelli, Alessandro, Eckstein, Anja, Führer-Sakel, Dagmar, Salvi, Mario, Sile, Saba, Francis-Sedlak, Megan, Holt, Robert J., and Smith, Terry J.

Subjects
genetic structures, Medizin, Antibodies, Monoclonal, Humanized, eye diseases, Graves Ophthalmopathy, Re-treatment, Long-term, Proptosis, Diplopia, Teprotumumab, Exophthalmos, Humans, Thyroid eye disease
Abstract

Purpose: To evaluate teprotumumab safety/efficacy in patients with thyroid eye disease (TED) who were nonresponsive or who experienced a disease flare. Design: The Treatment of Graves’ Orbitopathy to Reduce Proptosis with Teprotumumab Infusions in an Open-Label Clinical Extension Study (OPTIC-X) is a teprotumumab treatment and re-treatment trial following the placebo-controlled teprotumumab Phase 3 Treatment of Graves’ Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis with Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study (OPTIC) trial. Participants: Patients who previously received placebo (n = 37) or teprotumumab (n = 14) in OPTIC. Methods: OPTIC nonresponders or those who flared (≥2-mm increase in proptosis, ≥2-point increase in clinical activity score [CAS], or both) during follow-up were treated for the first time (previous placebo patients) or re-treated with teprotumumab in OPTIC-X with 8 infusions over 24 weeks. Main Outcome Measures: Proptosis response and safety. Secondary outcomes included proptosis, CAS, subjective diplopia, and quality-of-life. Results: Thirty-three of 37 placebo-treated OPTIC patients (89.2%) became proptosis responders (mean ± standard deviation, –3.5 ± 1.7 mm) when treated with teprotumumab in OPTIC-X. The responses were equivalent to the OPTIC study. In these responders, proptosis, CAS of 0 or 1, and diplopia responses were maintained in 29 of 32 patients (90.6%), 20 of 21 patients (95.2%), and 12 of 14 patients (85.7%), respectively, at follow-up week 48. The median TED duration was 12.9 months versus 6.3 months in those treated with teprotumumab in the OPTIC study. Of the 5 OPTIC teprotumumab nonresponders re-treated in OPTIC-X, 2 responded, 1 showed a proptosis reduction of 1.5 mm from OPTIC baseline, and 2 discontinued treatment early. Of the OPTIC teprotumumab responders who experienced flare, 5 of 8 patients (62.5%) responded when re-treated (mean proptosis reduction, 1.9 ± 1.2 mm from OPTIC-X baseline and 3.3 ± 0.7 mm from OPTIC baseline). Compared with published double-masked trials and their integrated follow-up, no new safety signals were identified. Mild hearing impairment was reported; 4 events occurred during first course of treatment, and 2 events reoccurred after re-treatment. Conclusions: Patients with TED of longer disease duration responded similarly to those treated earlier in the disease course. Patients with an insufficient initial response or flare may benefit from additional teprotumumab therapy. No new safety risk was identified; however additional postmarketing pharmacovigilance is ongoing.

Published
2022

19. Acellular cadaveric dermal matrix grafts for orbital wall reconstruction in patients with sinonasal malignancies.

Author

Verma, Rohan, Chen, Allison J., Murdock, Jennifer, Geltzeiler, Mathew, Wax, Mark K., Dailey, Roger A., and Ng, John D.

Subjects
PARANASAL sinuses, SQUAMOUS cell carcinoma, RADIOTHERAPY, FERTILITY preservation
Abstract

To describe the utilization of acellular cadaveric dermal matrix (ACDM) in patients undergoing orbital wall reconstruction after orbital preservation surgery for sinonasal malignancy. Retrospective case series of seven patients with sinonasal malignancy who had orbital reconstruction with ACDM implants from January 2012 to August 2020. Orbital preservation was performed in all patients with tumor extension up to and including periorbital. The main outcome measures were implant exposure, orbital infection, diplopia in primary gaze, enophthalmos, and eyelid malposition. Patients ranged 37–78 years old (median: 66 years) and included 4 females and 3 males. The median follow-up time was 9 months (range 6–43 months) from the date of surgery. Squamous cell carcinoma comprised the majority of tumors with all patients needing medial wall reconstruction. Three patients received postoperative radiation therapy. No patients had any implant exposure, orbital infection, enophthalmos, or eyelid malposition. ACDM grafts can be used safely in orbital wall reconstruction in patients with sinonasal malignancies. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

21. Fibrosis, gene expression and orbital inflammatory disease

Author

Rosenbaum, James T, Choi, Dongseok, Wilson, David J, Grossniklaus, Hans E, Harrington, Christina A, Dailey, Roger A, Ng, John D, Steele, Eric A, Czyz, Craig N, Foster, Jill A, Tse, David, Alabiad, Chris, Dubovy, Sander, Parekh, Prashant, Harris, Gerald J, Kazim, Michael, Patel, Payal, White, Valerie, Dolman, Peter, Edward, Deepak P, Alkatan, Hind, al Hussain, Hailah, Selva, Dinesh, Yeatts, Patrick, Korn, Bobby, Kikkawa, Don, Stauffer, Patrick, and Planck, Stephen R

Published
2015
Full Text
View/download PDF

22. Parallel Gene Expression Changes in Sarcoidosis Involving the Lacrimal Gland, Orbital Tissue, or Blood

Author

Rosenbaum, James T., Choi, Dongseok, Wilson, David J., Grossniklaus, Hans E., Harrington, Christina A., Sibley, Cailin H., Dailey, Roger A., Ng, John D., Steele, Eric A., Czyz, Craig N., Foster, Jill A., Tse, David, Alabiad, Chris, Dubovy, Sander, Parekh, Prashant, Harris, Gerald J., Kazim, Michael, Patel, Payal, White, Valerie, Dolman, Peter, Korn, Bobby S., Kikkawa, Don, Edward, Deepak P., Alkatan, Hind, al-Hussain, Hailah, Yeatts, R. Patrick, Selva, Dinesh, Stauffer, Patrick, and Planck, Stephen R.

Published
2015
Full Text
View/download PDF

26. Enrichment of IGF-1R and PPARγ signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesis.

Author

Verma, Rohan, Choi, Dongseok, Chen, Allison J., Harrington, Christina A., Wilson, David J., Grossniklaus, Hans E., Dailey, Roger A., Ng, John, Steele, Eric A., Planck, Stephen R., Korn, Bobby S., Kikkawa, Don, Czyz, Craig N., Foster, Jill A., Kazim, Michael, Harris, Gerald J., Edward, Deepak P., Al-Hussain, Haila, Maktabi, Azza M. Y., and Alabiad, Chris

Abstract

Background Orbital inflammatory disease (OID) encompasses a wide range of pathology including thyroid-associated orbitopathy (TAO), granulomatosis with polyangiitis (GPA), sarcoidosis and non-specific orbital inflammation (NSOI), accounting for up to 6% of orbital diseases. Understanding the underlying pathophysiology of OID can improve diagnosis and help target therapy. Aims To test the hypothesis that shared signalling pathways are activated in different forms of OID. Methods In this secondary analysis, pathway analysis was performed on the previously reported differentially expressed genes from orbital adipose tissue using patients with OID and healthy controls who were characterised by microarray. For the original publications, tissue specimens were collected from oculoplastic surgeons at 10 international centres representing four countries (USA, Canada, Australia and Saudi Arabia). Diagnoses were independently confirmed by two masked ocular pathologists (DJW, HEG). Gene expression profiling analysis was performed at the Oregon Health & Science University. Eighty-three participants were included: 25 with TAO, 6 with orbital GPA, 7 with orbital sarcoidosis, 25 with NSOI and 20 healthy controls. Results Among the 83 subjects (mean (SD) age, 52.8 (18.3) years; 70% (n=58) female), those with OID demonstrated perturbation of the downstream gene expressions of the IGF-1R (MAPK/RAS/RAF/MEK/ERK and PI3K/Akt/mTOR pathways), peroxisome proliferator-activated receptor-γ (PPARγ), adipocytokine and AMPK signalling pathways compared with healthy controls. Specifically, GPA samples differed from controls in gene expression within the insulin-like growth factor-1 receptor (IGF-1R, PI3K-Akt (p=0.001), RAS (p=0.005)), PPARγ (p=0.002), adipocytokine (p=0.004) or AMPK (p=<0.001) pathways. TAO, sarcoidosis and NSOI samples were also found to have statistically significant differential gene expression in these pathways. Conclusions Although OID includes a heterogenous group of pathologies, TAO, GPA, sarcoidosis and NSOI share enrichment of common gene signalling pathways, namely IGF-1R, PPARγ, adipocytokine and AMPK. Pathway analyses of gene expression suggest that other forms of orbital inflammation in addition to TAO may benefit from blockade of IGF-1R signalling pathways. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

27. Enrichment of IGF-1R and PPARγ signalling pathways in orbital inflammatory diseases: steps toward understanding pathogenesis

Author

Verma, Rohan, primary, Choi, Dongseok, additional, Chen, Allison J, additional, Harrington, Christina A, additional, Wilson, David J, additional, Grossniklaus, Hans E, additional, Dailey, Roger A, additional, Ng, John, additional, Steele, Eric A, additional, Planck, Stephen R, additional, Korn, Bobby S, additional, Kikkawa, Don, additional, Czyz, Craig N, additional, Foster, Jill A, additional, Kazim, Michael, additional, Harris, Gerald J, additional, Edward, Deepak P, additional, Al-Hussain, Haila, additional, Maktabi, Azza M Y, additional, Alabiad, Chris, additional, Garcia, Armando, additional, and Rosenbaum, James T, additional

Published
2021
Full Text
View/download PDF

40. CONTRIBUTORS

Author

Abbott, Richard L., primary, Afshari, Natalie A., additional, Agrawal, Jaya, additional, Agrawal, Shishir, additional, Agrawal, Trilok P., additional, Akduman, Levent, additional, Akpek, Esen K., additional, Al-Sayyed, Amal, additional, Albini, Thomas A., additional, Alcorn, Deborah M., additional, Alwitry, Amar, additional, Amzel, Anouk, additional, Anderson, Nicole J., additional, Ansari, Ejaz A., additional, Antoszyk, Andrew, additional, Antoszyk, James H., additional, Aquavella, James V., additional, Arain, Sumaira A., additional, Arévalo, J. Fernando, additional, Arunagiri, Guruswami, additional, Arzabe, Carlos W., additional, Atchaneeyasakul, La-ongsri, additional, Atilla, Huban, additional, Aykan, Ümit, additional, Ayres, Brandon D., additional, Barbón, Juan J., additional, Bailey, Kristi, additional, Baloh, Frank G., additional, Barequet, Irina S., additional, Barkhuizen, André, additional, Bearn, Michael A., additional, Belfort, Rubens, additional, Bellows, A. Robert, additional, Berrocal, Audina M., additional, Bettink-Remeijer, Marijke Wefers, additional, Bhandari, Anuja, additional, Bhatti, M. Tariq, additional, Blumenkranz, Mark S., additional, Boboridis, Kostas G., additional, Bolling, James P., additional, Boniuk, Vivien, additional, Botelho, Paul Jorge, additional, Brazis, Paul W., additional, Bremner, Fion D., additional, Buckley, Edward G., additional, Bullock, John D., additional, Bushley, David Matthew, additional, Caldeira, Jorge Alberto F., additional, Carricajo, Anne, additional, Cavallini, Gian Maria, additional, Chan, Matilda Frances, additional, Chandler, Damon B., additional, Channa, H., additional, Char, Devron H., additional, Charles, Steve, additional, Chen, Teresa C., additional, Ching, Steven S.T., additional, Chiquet, Christophe, additional, Hyunchul, Phillip, additional, Chou, Timothy Y., additional, Christiansen, Stephen P., additional, Chung, Kelly D., additional, Cioffi, George A., additional, Clarke, Michael P., additional, Coats, David K., additional, Cohen, Elisabeth J., additional, Conway, R. Max, additional, Creuzot-Garcher, Catherine, additional, Cunningham, Emmett T., additional, Curtis, Theodore H., additional, Dailey, Roger A., additional, Davis, Richard M., additional, Cock, Romain De, additional, de Faber, Jan-Tjeerd H.N., additional, de la Mano, Daniel, additional, Dekkers, Nick W.H.M., additional, Monte, Monte Anthony Del, additional, Rocca, David A. Della, additional, Rocca, Robert C. Della, additional, Dhaliwal, Deepinder K., additional, Do, Diana V., additional, Dolman, Peter J., additional, Donahue, Sean P., additional, Donnenfeld, Eric D., additional, Duguid, Graham, additional, Duker, Jay S., additional, Dunn, James P., additional, Dunn, Steven P., additional, Duong, Hon-Vu Q., additional, Egan, Robert A., additional, Eichler, Michael D., additional, El-Dairi, Mays, additional, Ellis, Forrest J., additional, Emerson, Geoffrey, additional, Emerson, M. Vaughn, additional, Enyedi, Laura B., additional, Evans, Teodoro, additional, Falardeau, Julie, additional, Faris, Bishara M., additional, Feitl, Marianne E., additional, Felton, Warren L., additional, Feman, Stephen S., additional, ffytche, Timothy J, additional, Flaxel, Christina J., additional, Foroozan, Rod, additional, Foster, Allen, additional, Fraunfelder, Frederick T., additional, Fraunfelder, Frederick W., additional, Freeman, H. Mackenzie, additional, Friedlaender, Mitchell H., additional, Frohman, Larry P., additional, Fung, Wayne E., additional, Gain, Philippe, additional, Gaitan, Jaime R., additional, Gancher, Stephen, additional, Gard, Tim, additional, Gattey, Devin M., additional, Gehlbach, Peter L., additional, Ghajarnia, Mehdi, additional, Ghanem, Vinícius Coral, additional, Ghosh, Amit Kumar, additional, Ghosh, Chandak, additional, Giegengack, Matthew, additional, Gladstone, Geoffrey, additional, Gold, Daniel H., additional, Golub, Richard L., additional, Gombos, Dan S., additional, Gombos, George M., additional, Good, William V., additional, Goodman, Shawn, additional, Gottsch, John D., additional, Goverdhan, Srinivas, additional, Grimson, Baird S., additional, Güemes, Adolfo, additional, Guerra, Roberto, additional, Haller, Julia A., additional, Hammersmith, Kristin M., additional, Handelman, Irvin L., additional, Hargrove, Roderick N., additional, Harney, Michael S., additional, Harper, Richard A., additional, Hatt, Sarah R., additional, Hawkins, Barbara S., additional, Hayreh, Sohan S., additional, Heiligenhaus, Arnd, additional, Heinz, Carsten, additional, Herndon, Leon W., additional, Hickman, Simon J., additional, Hirano, Koji, additional, Holland, Edward J., additional, Holland, Gary N., additional, Holz, Eric R., additional, Hommura, Sachiko, additional, Horn, Jeffrey D., additional, Hornick, Richard B., additional, Hoskins, H. Dunbar, additional, Hung, James W., additional, Hunter, Brian A., additional, Hunter, Krista A., additional, Hunyor, Alex P., additional, Hurwitz, Brian, additional, Hwang, Thomas S., additional, Hyndiuk, Robert A., additional, Ilhan-Sarac, Ozge, additional, Ing, Edsel, additional, Ino-ue, Masanori, additional, Isada, Carlos M., additional, Iturriaga, Saylin, additional, Iuorno, Joseph D., additional, Iwach, Andrew G., additional, Iyer, Mohan N., additional, Izquierdo, Natalio J., additional, Jampol, Lee M., additional, Johnston, Suzanne, additional, Kadayifçilar, Sibel, additional, Kaden, Ian H., additional, Kaimbo, Dieudonne Kaimbo Wa, additional, Kapur, Rashmis, additional, Kastl, Peter R., additional, Katsavounidou, Garyfallia, additional, Kazerouni, Ayat, additional, Kazim, Michael, additional, Kedhar, Sanjay R., additional, Keech, Ronald V., additional, Kersten, Robert C., additional, Keys, Marshall P., additional, Khanna, Sangeeta, additional, Khaw, Peng Tee, additional, Kinyoun, James L., additional, Kirwan, Caitriona, additional, Kivelä, Tero, additional, Klein, Michael L., additional, Klotz, Stephen A., additional, Ko, John, additional, Kowalski, Regis P., additional, Krachmer, Jay H., additional, Krupin, Theodore, additional, Kuhn, Ferenc, additional, Kulkarni, Abhaya Vivek, additional, Kwun, Robert C., additional, Laibson, Peter R., additional, Lakhanpal, Rohit R., additional, Lam, Byron L., additional, Lamer, Laurent, additional, Lawlor, David P., additional, Lawton, Andrew W., additional, Leahey, Alan B., additional, LeBoyer, Russell, additional, Lee, Andrew G., additional, Lee, Wen-Hsiang, additional, Lee, William Barry, additional, Lehman, Sharon S., additional, Leibowitz, Howard M., additional, Leong, James, additional, Levin, Alex V., additional, Levin, Leonard A., additional, Levine, Mark R., additional, Levy, Norman S., additional, Liesegang, Thomas J., additional, Lim, Lyndell L., additional, Lin, Linda H., additional, Lisman, Richard D., additional, Litoff, David, additional, Liu, James C., additional, Loft, Evan, additional, Lubritz, Ronald R., additional, Mabey, David C.W., additional, Mackie, Ian A., additional, Maguluri, Srilakshmi, additional, Maliki, M., additional, Mamalis, Nick, additional, Mannis, Mark J., additional, Mansberger, Steven L., additional, Mansour, Ahmad M., additional, Marcon, Alexandre S., additional, Marcon, Italo M., additional, Marsh, Peter B., additional, Mather, Rookaya, additional, Mathers, William D., additional, Saari, K. Matti, additional, Mawn, Louise A., additional, McAllum, Penny J., additional, McCallum, Rex M., additional, McCluskey, Peter, additional, McCormick, Gregory J., additional, McCormick, Steven A., additional, McCulley, James P., additional, McHenry, John G., additional, McNab, Alan A., additional, Mee, Jared J., additional, Meier, Douglas L., additional, Meisler, David M., additional, Merin, Saul C., additional, Meyer, Dale R., additional, Meyer, Roger F., additional, Michels, Kevin S., additional, Milman, Tatyana, additional, Mintz, Roni, additional, Morel, Chantal F, additional, Morris, William R., additional, Moster, Mark L., additional, Mourani, John, additional, Muccioli, Cristina, additional, Mudumbai, Raghu C., additional, Murillo-Lopez, Fernando H., additional, Myint, Shoib, additional, Nagra, Parveen K, additional, Naoumi, A, additional, Nassif, John, additional, Nee, Michelle T., additional, Netto, Marcelo V., additional, Ng, John D., additional, Nguyen, Hau T., additional, Nguyen, Quan Dong, additional, O'Day, Denis M., additional, O'Day, A. Justin, additional, O'Halloran, Henry S., additional, O'Keefe, Michael, additional, Okamoto, Fumiki, additional, Olson, Richard J., additional, Orcutt, James C., additional, Dundar, Sema Oruc, additional, Osbourne, Aaron, additional, Palazzi, Maristela Amaral, additional, Palmer, Earl A., additional, Papadopoulos, Maria, additional, Parnell, Jeffrey R., additional, Parsa, Cameron F., additional, Patel, Sanjay V., additional, Patterson, Emily, additional, Pendergast, Scott D., additional, Perry, Henry D., additional, Peters, Keith Roberson, additional, Po, Stephanie M., additional, Pokroy, Russell, additional, Putterman, Allen Michael, additional, Queiro, Rubén, additional, Rafiei, Nastaran, additional, Rahmani, Bahram, additional, Rapuano, Christopher J, additional, Rasheed, Karim, additional, Rathinam, S.R., additional, Raymond, Lawrence A., additional, Read, Russell W., additional, Lafayette, August, additional, Recchia, Franco M., additional, Reidy, James J., additional, Reynolds, Adam C., additional, Rich, Larry F., additional, Ritch, Robert, additional, Robb, Richard M., additional, Robert, Pierre-Yves, additional, Robertson, Joseph E., additional, Roh, Shiyoung, additional, Romanet, Jean-Paul, additional, Rootman, Jack, additional, Roque, Barbara L., additional, Roque, Manolette R., additional, Rosenbaum, Arthur L., additional, Rosenbaum, James Todd, additional, Roy, F. Hampton, additional, Rundle, Paul A., additional, Sadun, Alfredo A., additional, Saffra, Norman A., additional, Salim, Sarwat, additional, Samples, John R., additional, Santiago, Alvina Pauline D, additional, Saperstein, David A., additional, Saunders, Richard A., additional, Savage, James A., additional, Scheufele, Tina A., additional, Schiedler, Vivian, additional, Schlesinger, Thomas K., additional, Schlossman, Abraham, additional, Schwartz, Lee K., additional, Scott, Ingrid U., additional, Scruggs, Jennifer, additional, Segal, Ernesto I., additional, Shalaby, Ismail A., additional, Sheikh, Aziz, additional, Sheppard, John D., additional, Sherman, Mark D., additional, Shields, Carol L., additional, Shields, Jerry A., additional, Singh, Amarpreet, additional, Singh, Christopher N., additional, Singman, Eric L., additional, Siracuse-Lee, Donna, additional, Smalley, Aaron D., additional, Smith, Patricia W., additional, Solomon, Anthony W., additional, Souhail, Hassane, additional, Spitzberg, Daniel H., additional, Spoor, Thomas C., additional, Stamper, Robert L., additional, Stark, Walter J., additional, Steele, Eric A., additional, Steinemann, Thomas L., additional, Stout, Ann U., additional, Stout, J. Timothy, additional, Stulting, R. Doyle, additional, Sugar, Alan, additional, Sugar, Joel, additional, Suh, Donny W., additional, Suhler, Eric B., additional, Sullivan, John H., additional, Sutphin, John Everett, additional, Swan, Kenneth C., additional, Tabbara, Khalid F., additional, Tamber, Mandeep S., additional, Tanna, Angelo P., additional, Tatlipinar, Sinan, additional, Tayani, Ramin, additional, Teichmann, Klaus D., additional, Terry, Mark A., additional, Tham, Clement Chee Yung, additional, Therzaz, A., additional, Thuret, Gilles, additional, Tinley, Christopher Graham, additional, Tongue, Andrea C., additional, Torres, Rodrigo J., additional, Tower, Robert N., additional, Traboulsi, Elias I, additional, Trikha, Rupan, additional, Tripathi, Brenda J., additional, Tripathi, Ramesh C., additional, Tugal-Tutkun, Ilknur, additional, Tung, Irene, additional, Evendingen, Judith A. M. Van, additional, Vaudaux, Jean D., additional, Wairagkar, Niteen S, additional, Walrath, Joseph D., additional, Walsh, Rory McConn, additional, Walton, David S., additional, Warwar, Ronald E., additional, Watson, Peter G., additional, Weiter, John J., additional, Weleber, Richard G., additional, Wertz, Fleming D., additional, Westra, Igor, additional, Wheeler, David T., additional, Wilkinson, Charles P., additional, Wilson, David J., additional, Wilson, M. Edward, additional, Wilson, Matthew W., additional, Wilson, Steven E, additional, Wobig, John L., additional, Wood, Terry D., additional, Wu, Lihteh, additional, Yalcinbayir, Ozgur, additional, Ying, Howard Shann-Cherng, additional, Youssef, Peter N., additional, and Zaidman, Gerald W., additional

Published
2008
Full Text
View/download PDF

42. Facial Soft-Tissue Fillers: Assessing the State of the Science conference---Proceedings report

Author

Hanke, William C., Rohrich, Rod J., Busso, Mariano, Carruthers, Alastair, Carruthers, Jean, Fagien, Steven, Fitzgerald, Rebecca, Glogau, Richard, Greenberger, Phyllis E., Lorenc, Paul Z., Marmur, Ellen S., Monheit, Gary D., Pusic, Andrea, Rubin, Mark G., Rzany, Berthold, Sclafani, Anthony, Taylor, Susan, Weinkle, Susan, McGuire, Michael F., Pariser, David M., Casas, Laurie A., Collishaw, Karen J., Dailey, Roger A., Duffy, Stephen C., Edgar, Elizabeth Jan, Greenan, Barbara L., Haenlein, Kelly, Henrichs, Ronald A., Hume, Keith M., Lum, Flora, Nielsen, David R., Poulsen, Lisle, Shoaf, Lori, Seward, William, Begolka, Wendy Smith, Stanton, Robert G., Svedman, Katherine J., Thomas, Regan J., Sykes, Jonathan M., Wargo, Carol, and Weiss, Robert A.

Published
2011

43. Teprotumumab for the Treatment of Active Thyroid Eye Disease

Author

Douglas, Raymond S., primary, Kahaly, George J., additional, Patel, Amy, additional, Sile, Saba, additional, Thompson, Elizabeth H.Z., additional, Perdok, Renee, additional, Fleming, James C., additional, Fowler, Brian T., additional, Marcocci, Claudio, additional, Marinò, Michele, additional, Antonelli, Alessandro, additional, Dailey, Roger, additional, Harris, Gerald J., additional, Eckstein, Anja, additional, Schiffman, Jade, additional, Tang, Rosa, additional, Nelson, Christine, additional, Salvi, Mario, additional, Wester, Sara, additional, Sherman, Jeffrey W., additional, Vescio, Thomas, additional, Holt, Robert J., additional, and Smith, Terry J., additional

Published
2020
Full Text
View/download PDF

46. Facial Soft-Tissue Fillers conference: Assessing the State of the Science

Author

Hanke, William C., Rohrich, Rod J., Busso, Mariano, Carruthers, Alastair, Carruthers, Jean, Fagien, Steven, Fitzgerald, Rebecca, Glogau, Richard, Greenberger, Phyllis E., Lorenc, Paul Z., Marmur, Ellen S., Monheit, Gary D., Pusic, Andrea, Rubin, Mark G., Rzany, Berthold, Sclafani, Anthony, Taylor, Susan, Weinkle, Susan, McGuire, Michael F., Pariser, David M., Casas, Laurie A., Collishaw, Karen J., Dailey, Roger A., Duffy, Stephen C., Edgar, Elizabeth Jan, Greenan, Barbara L., Haenlein, Kelly, Henrichs, Ronald A., Hume, Keith M., Lum, Flora, Nielsen, David R., Poulsen, Lisle, Shoaf, Lori, Seward, William, Begolka, Wendy Smith, Stanton, Robert G., Svedman, Katherine J., Thomas, Regan J., Sykes, Jonathan M., Wargo, Carol, and Weiss, Robert A.

Published
2011

Catalog

Books, media, physical & digital resources
See catalog results